| Attribute |
Value |
| 52 Week Change |
-0.6395556 |
| Address1 |
1 Commonwealth Lane |
| Address2 |
No. 08-22 |
| All Time High |
9.25 |
| All Time Low |
0.68 |
| Ask |
1.35 |
| Ask Size |
1 |
| Average Daily Volume10 Day |
26,590 |
| Average Daily Volume3 Month |
78,476 |
| Average Volume |
78,476 |
| Average Volume10Days |
26,590 |
| Beta |
0.071 |
| Bid |
1.07 |
| Bid Size |
3 |
| Book Value |
0.3272128 |
| City |
Singapore |
| Compensation As Of Epoch Date |
1,735,603,200 |
| Country |
Singapore |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.8301 |
| Current Ratio |
2.644 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
0.87 |
| Day Low |
0.82 |
| Debt To Equity |
8.411 |
| Display Name |
CytoMed Therapeutics |
| Dividend Yield |
0.0 |
| Earnings Timestamp End |
1,745,870,400 |
| Earnings Timestamp Start |
1,745,870,400 |
| Ebitda |
-3,558,277 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-2.559 |
| Enterprise To Revenue |
11.541 |
| Enterprise Value |
9,105,946 |
| Eps Forward |
-0.15 |
| Eps Trailing Twelve Months |
-0.23 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
0.89522 |
| Fifty Day Average Change |
-0.06511998 |
| Fifty Day Average Change Percent |
-0.07274187 |
| Fifty Two Week Change Percent |
-63.95556 |
| Fifty Two Week High |
3.68 |
| Fifty Two Week High Change |
-2.8499 |
| Fifty Two Week High Change Percent |
-0.7744293 |
| Fifty Two Week Low |
0.68 |
| Fifty Two Week Low Change |
0.1501 |
| Fifty Two Week Low Change Percent |
0.22073528 |
| Fifty Two Week Range |
0.68 - 3.68 |
| Financial Currency |
SGD |
| First Trade Date Milliseconds |
1,681,479,000,000 |
| Float Shares |
3,596,346 |
| Forward Eps |
-0.15 |
| Forward P E |
-5.534 |
| Free Cashflow |
-2,367,307 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
42 |
| Fullday Change |
0.018700004 |
| Fullday Change Percent |
2.3046591 |
| Fullday Price |
0.8301 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.85893995 |
| Gross Profits |
677,741 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.69866997 |
| Held Percent Institutions |
0.0014 |
| Implied Shares Outstanding |
11,934,908 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,023-04-14 |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
CytoMed Therapeutics Limited, a clinical stage biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. The company's lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord-derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore; and Business and Research Collaboration Agreement with SunAct Cancer Institute Private Limited to conduct clinical trials for the GMP grade CTM-GDT. CytoMed Therapeutics Limited was incorporated in 2018 and is headquartered in Singapore. |
| Long Name |
CytoMed Therapeutics Limited |
| Market |
us_market |
| Market Cap |
9,907,167 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_647650276 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-3,507,149 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
10,761,963 |
| Number Of Analyst Opinions |
1 |
| Open |
0.83 |
| Operating Cashflow |
-3,744,038 |
| Operating Margins |
-4.76093 |
| Phone |
65 6250 7738 |
| Previous Close |
0.8114 |
| Price Hint |
4 |
| Price To Book |
2.5368812 |
| Price To Sales Trailing12 Months |
12.55596 |
| Profit Margins |
0.0 |
| Quick Ratio |
1.506 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
0.018700004 |
| Regular Market Change Percent |
2.3046591 |
| Regular Market Day High |
0.87 |
| Regular Market Day Low |
0.82 |
| Regular Market Day Range |
0.82 - 0.87 |
| Regular Market Open |
0.83 |
| Regular Market Previous Close |
0.8114 |
| Regular Market Price |
0.8301 |
| Regular Market Time |
1,791,908,887 |
| Regular Market Volume |
12,365 |
| Return On Assets |
-0.3252 |
| Return On Equity |
-0.56168 |
| Revenue Growth |
-0.159 |
| Revenue Per Share |
0.067 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
11,934,908 |
| Shares Percent Shares Out |
0.0014 |
| Shares Short |
17,102 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
6,370 |
| Short Name |
CytoMed Therapeutics Limited |
| Short Percent Of Float |
0.0047999998 |
| Short Ratio |
1.26 |
| Source Interval |
15 |
| Symbol |
GDTC |
| Target High Price |
4.16 |
| Target Low Price |
4.16 |
| Target Mean Price |
4.16 |
| Target Median Price |
4.16 |
| Total Cash |
1,458,764 |
| Total Cash Per Share |
0.122 |
| Total Debt |
454,134 |
| Total Revenue |
789,041 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-0.23 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
1.00986 |
| Two Hundred Day Average Change |
-0.17976004 |
| Two Hundred Day Average Change Percent |
-0.1780049 |
| Type Disp |
Equity |
| Volume |
12,365 |
| Website |
https://w2.cytomed.sg |
| Zip |
149,544 |